Therefore, it can be inferred that the low levels of ROS/RNS in the TME cannot inhibit tumor growth, but facilitate tumor immune escape via the PD-1/PD-L1 pathway through CD8+T cells. This evidence concerns the gene CD8A and neoplasm.